These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 15901744)

  • 21. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotan.
    Mondick JT; Oo C; Patel D; Fujitani T; Shimizu K; Barrett JS
    Am J Ther; 2009; 16(2):106-15. PubMed ID: 19300037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period.
    Mukherjee A; Dombi T; Wittke B; Lalonde R
    Clin Pharmacol Ther; 2009 Jan; 85(1):56-63. PubMed ID: 18800037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure.
    Smilde TD; Linssen GC; Gallemann D; Kuhn T; Machnig T; Mol PG; Hillege HL; Van Wijk LM; Van Dijk RB; Van Veldhuisen DJ
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):507-16. PubMed ID: 16300166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes.
    Muller AE; DeJongh J; Oostvogel PM; Voskuyl RA; Dörr PJ; Danhof M; Mouton JW
    Am J Obstet Gynecol; 2008 Jan; 198(1):108.e1-6. PubMed ID: 18061131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP
    J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of myocardial infarction by postischemic administration of the calpain inhibitor A-705253 in comparison to the Na(+)/H(+) exchange inhibitor Cariporide in isolated perfused rabbit hearts.
    Neuhof C; Fabiunk V; Speth M; Möller A; Fritz F; Tillmanns H; Neuhof H; Erdogan A
    Biol Chem; 2008 Dec; 389(12):1505-12. PubMed ID: 18844452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.
    Barr FE; Tirona RG; Taylor MB; Rice G; Arnold J; Cunningham G; Smith HA; Campbell A; Canter JA; Christian KG; Drinkwater DC; Scholl F; Kavanaugh-McHugh A; Summar ML
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits.
    Yamada K; Matsui K; Ogawa S; Yamamoto S; Mori M; Kitano M; Ohashi N
    Eur J Pharmacol; 2005 Oct; 521(1-3):115-23. PubMed ID: 16183058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours.
    Trocòniz IF; Garrido MJ; Segura C; Cendrós JM; Principe P; Peraire C; Obach R
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):727-35. PubMed ID: 16261364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest.
    Klass O; Fischer UM; Perez E; Easo J; Bosse M; Fischer JH; Tossios P; Mehlhorn U
    Ann Thorac Surg; 2004 Feb; 77(2):658-63. PubMed ID: 14759455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
    Kusumoto K; Igata H; Abe A; Ikeda S; Tsuboi A; Imamiya E; Fukumoto S; Shiraishi M; Watanabe T
    Br J Pharmacol; 2002 Apr; 135(8):1995-2003. PubMed ID: 11959803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
    Zeymer U; Suryapranata H; Monassier JP; Opolski G; Davies J; Rasmanis G; Linssen G; Tebbe U; Schröder R; Tiemann R; Machnig T; Neuhaus KL;
    J Am Coll Cardiol; 2001 Nov; 38(6):1644-50. PubMed ID: 11704395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery.
    Weber W; Harnisch L; Jessel A;
    Clin Pharmacol Ther; 2002 Jun; 71(6):457-67. PubMed ID: 12087349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction.
    Bhattaram VA; Nagaraja NV; Peters T; Machnig T; Kroesser S; Kovar A; Derendorf H
    J Clin Pharmacol; 2005 Jun; 45(6):631-9. PubMed ID: 15901744
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.